Abstract
Introduction
In plants, isopentenyl diphosphate, the precursor of isoprenoids, is synthesized either via the classical acetate/mevalonate pathway (cytosolic isoprenoids, e.g. sterols) or via the non-mevalonate 1 -deoxy-D-xylulose S-phosphate/2-C-methyIerythritol4-phosphate (DOXP/MEP) pathway used for plastidic isoprenoids such as phytol, carotenoids, isoprene or plastoquinone-9 [ l]. Until now, five enzymes of the DOXP/MEP pathway have been discovered.
T h e first step is the formation of DOXP from pyruvate and glyceraldehyde 3-phosphate, catalysed by the enzyme DOXP synthase (DXS). T h e enzyme was cloned from bacteria [2, 3] and plants [4, 5] . In the second step the DOXP reductoisomerase (DXR), which was cloned from Escherichia coli [6] and plants [7, 8] , catalyses the C-C skeleton rearrangement and reduction of DOXP to MEP. T h e three subsequent steps are reviewed in [9] . fosmidomycin, an antibacterial drug and herbicide [12] . It specifically blocks the DXR from plants [7] and bacteria [13] . Until now there has been no clear inhibitor of the DXS, yet we show here that a derivative of the herbicide clomazone, known to block carotenoid and chlorophyll biosynthesis, affects the DXS.
Investigations of DXS and DXR
For inhibitor studies, the D X S of Chlamydomonas and the DXR of Arabidopsis thaliana and barley were used. As described earlier [7] , we have cloned the DXS of Chlamydornonas and the DXR of A . thaliana. For the expression of the A . thaliana DXR and Chlamydomonas D X S with an Nterminal His tag, the inserts of pETSb-DXR and pET5b-DXS [7] were cloned into the expression vector pET28b. For protein expression of the resulting vectors pET28b-DXR and pET28b-DXS, E. coli JM109(DE3) (Promega) was used. For further investigations the recombinant enzymes were purified by applying cell-free extracts with DXS or DXR to a Zn2+-chelating column (Supelco HiTrap chelating), elution was performed with a linear gradient of imidazole. One single protein band showed up in the SDS/PAGE in both cases (Figure 1) . For monitoring the activity of DXS an assay with radiolabelled pyruvate was used [7] . In the case of DXR, either an assay with radiolabelled DOXP [7] or an optical test measuring the oxidation of NADPH at 340 nm was used.
Results and discussion
DXR activity was detected in crude protein extracts of etiolated barley shoots. T h e DXR enzyme is active at p H 6.8-9.2 with an optimum at pH 8.1, which is typical for enzymes active in the chloroplast stroma.
T h e inhibition of the DXR by fosmidomycin is shown in Figure 2 for A . thaliana and barley
DXRs. T h e inhibition is dose-dependent. T h e
I,, values were 0.28pM for Arabidopsis and 0.7pM for barley at 0.25 and 0.5 mM DOXP, respectively. This is further confirmation of the previously described inhibitory effect of fosmidomycin on carotenoid and chlorophyll accumulation in plants [12] . It is a specific inhibitor of the DXR of plants [7] , bacteria [13] and the malaria parasite P . falciparum [ l 13 . So far, no I,, value had been given for plants. T h e I,, value is much higher than that reported for the enzyme of E. coli [13] .
T h e reason could lie in structural differences between the bacterial and plant DXRs. It is Concentration of fosrnidornycin (pM) important to know whether there are differences between bacterial and plant enzymes of the DOXP/MEP pathway. This would be essential with respect to the development of herbicides only affecting plants or of antibacterial drugs specifically affecting pathogenic bacteria.
The herbicide clomazone and one of its breakdown products (ketoclomazone) were tested on the first two enzymes of the DOXP/MEP pathway, DXS and DXR. Whereas clomazone itself had no effect on the activity of DXS and DXR, our first experiments showed that one of its derivatives, ketoclomazone, inhibits the DXS of Chlamydomonas (I5o value approx. 0.1 mM). This and the fact that clomazone does not inhibit the isoprene emission, whereas ketoclomazone does [14] , might indicate that it is not clomazone that is the active herbicide but its breakdown product, ketoclomazone.
